# 22nd International Conference on Cytochrome P450: Biochemistry, Biophysics, and Biotechnology

> **NIH NIH R13** · VIRGINIA COMMONWEALTH UNIVERSITY · 2020 · $7,000

## Abstract

The goal of this conference is to bring an interdisciplinary group of scientists from around the world whose
research is focused on cytochromes P450 to provide networking opportunities, updates on cutting-edge
technologies, opportunities for new collaborations, and to engage young scientists. These enzymes are
responsible for a dazzling array of transformations in the disposition of xenobiotics and biosyntheses of
hormones. Over 70% of drugs are metabolized by CYPs; hence tremendous resources are devoted to
identification of substrates and inhibitors in drug development to avoid later attrition, or adverse drug
interactions following introduction into the clinic. Accordingly, CYP research has positively impacted the fields
of xenobiotic metabolism, endocrinology, toxicology, nutrition, and biotechnology. The ICCP450 series is the
premiere meeting in the field, is small enough (~200-250 delegates) to facilitate interactions between
delegates, but large enough to attract prominent speakers. The conference was last held in the United States
in 2013 on the campus of the University of Washington in Seattle. ICCP450 2021 will be held at the Hyatt
Regency Crystal City Hotel in Arlington, Virginia near Washington, D. C. from June 13-17, 2021. Nearby
airports offer convenient access for both international and U. S. delegates. ICCP450 2021 will continue to
focus on its traditional areas of strength, including advancements structural biology, novel biophysical
methods, xenobiotic/endobiotic metabolism, and genetic control of P450 expression. However, additional goals
of this meeting are to strengthen contributions from expert investigators that have adopted the powerful tools of
metabolomics, synthetic biology, and high-performance computation. The meeting format facilitates
interactions between trainees, junior and established investigators with representation from women and
underrepresented minorities. The meeting will consist of a keynote lecture on Sunday (6/13) followed by twelve
plenary lectures and more than 80 invited talks (6/14-17). There will be two posters sessions for scientists to
present their work and participate in informal discussions. Some of the poster abstracts will be selected for
short oral presentations. Here we request funds to support student travel awards (registration and lodging),
plenary speaker registration, and production of electronic/printed materials.

## Key facts

- **NIH application ID:** 10070944
- **Project number:** 1R13ES032310-01
- **Recipient organization:** VIRGINIA COMMONWEALTH UNIVERSITY
- **Principal Investigator:** Lisa Sale Shock
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $7,000
- **Award type:** 1
- **Project period:** 2020-07-15 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10070944

## Citation

> US National Institutes of Health, RePORTER application 10070944, 22nd International Conference on Cytochrome P450: Biochemistry, Biophysics, and Biotechnology (1R13ES032310-01). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10070944. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*